{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:29:49Z","timestamp":1791300589973,"version":"4.1.0"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,4,12]],"date-time":"2010-04-12T00:00:00Z","timestamp":1271030400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1750-1172-5-5","type":"journal-article","created":{"date-parts":[[2010,4,13]],"date-time":"2010-04-13T02:15:13Z","timestamp":1271124913000},"source":"Crossref","is-referenced-by-count":265,"title":["Mucopolysaccharidosis VI"],"prefix":"10.1186","volume":"5","author":[{"given":"Vassili","family":"Valayannopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Nicely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Harmatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Turbeville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,4,12]]},"reference":[{"key":"168_CR1","first-page":"1849","volume":"71","author":"P Maroteaux","year":"1963","unstructured":"Maroteaux P, Leveque B, Marie J, Lamy M: A new dysostosis with urinary elimination of chondroitin sulfate B. Presse Med. 1963, 71: 1849-1852.","journal-title":"Presse Med"},{"key":"168_CR2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/BF00288275","volume":"82","author":"T Litjens","year":"1989","unstructured":"Litjens T, Baker EG, Beckmann KR, Morris CP, Hopwood JJ, Callen DF: Chromosomal localization of ARSB, the gene for human N-acetylgalactosamine-4-sulphatase. Hum Genet. 1989, 82: 67-68. 10.1007\/BF00288275.","journal-title":"Hum Genet"},{"key":"168_CR3","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1042\/bj2340507","volume":"234","author":"JJ Hopwood","year":"1986","unstructured":"Hopwood JJ, Elliott H, Muller VJ, Saccone GT: Diagnosis of Maroteaux-Lamy syndrome by the use of radiolabelled oligosaccharides as substrates for the determination of arylsulphatase B activity. Biochem J. 1986, 234: 507-514.","journal-title":"Biochem J"},{"key":"168_CR4","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1203\/01.PDR.0000113789.30640.5C","volume":"55","author":"A Crawley","year":"2004","unstructured":"Crawley A, Ramsay SL, Byers S, Hopwood J, Meikle PJ: Monitoring dose response of enzyme replacement therapy in feline mucopolysaccharidosis type VI by tandem mass spectrometry. Pediatr Res. 2004, 55: 585-591. 10.1203\/01.PDR.0000113789.30640.5C.","journal-title":"Pediatr Res"},{"key":"168_CR5","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1067\/mpd.2002.122394","volume":"140","author":"C Dionisi-Vici","year":"2002","unstructured":"Dionisi-Vici C, Rizzo C, Burlina AB, Caruso U, Sabetta G, Uziel G, et al: Inborn errors of metabolism in the Italian pediatric population: a national retrospective survey. J Pediatr. 2002, 140: 321-327. 10.1067\/mpd.2002.122394.","journal-title":"J Pediatr"},{"key":"168_CR6","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s10545-005-0112-z","volume":"28","author":"F Baehner","year":"2005","unstructured":"Baehner F, Schmiedeskamp C, Krummenauer F, Miebach E, Bajbouj M, Whybra C, et al: Cumulative incidence rates of the mucopolysaccharidoses in Germany. J Inherit Metab Dis. 2005, 28: 1011-1017. 10.1007\/s10545-005-0112-z.","journal-title":"J Inherit Metab Dis"},{"key":"168_CR7","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1111\/j.1651-2227.2008.00965.x","volume":"97","author":"G Malm","year":"2008","unstructured":"Malm G, Lund AM, Mansson JE, Heiberg A: Mucopolysaccharidoses in the Scandinavian countries: incidence and prevalence. Acta Paediatr. 2008, 97: 1577-1581. 10.1111\/j.1651-2227.2008.00965.x.","journal-title":"Acta Paediatr"},{"key":"168_CR8","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ymgme.2006.02.013","volume":"88","author":"PJ Meikle","year":"2006","unstructured":"Meikle PJ, Grasby DJ, Dean CJ, Lang DL, Bockmann M, Whittle AM, et al: Newborn screening for lysosomal storage disorders. Mol Genet Metab. 2006, 88: 307-314. 10.1016\/j.ymgme.2006.02.013.","journal-title":"Mol Genet Metab"},{"key":"168_CR9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s004399900075","volume":"105","author":"BJ Poorthuis","year":"1999","unstructured":"Poorthuis BJ, Wevers RA, Kleijer WJ, Groener JE, de Jong JG, van Weely S, et al: The frequency of lysosomal storage diseases in The Netherlands. Hum Genet. 1999, 105: 151-156.","journal-title":"Hum Genet"},{"key":"168_CR10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/sj.ejhg.5201044","volume":"12","author":"R Pinto","year":"2004","unstructured":"Pinto R, Caseiro C, Lemos M, Lopes L, Fontes A, Ribeiro H, et al: Prevalence of lysosomal storage diseases in Portugal. Eur J Hum Genet. 2004, 12: 87-92. 10.1038\/sj.ejhg.5201044.","journal-title":"Eur J Hum Genet"},{"key":"168_CR11","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1007\/s004310050685","volume":"156","author":"JC Coelho","year":"1997","unstructured":"Coelho JC, Wajner M, Burin MG, Vargas CR, Giugliani R: Selective screening of 10,000 high-risk Brazilian patients for the detection of inborn errors of metabolism. Eur J Pediatr. 1997, 156: 650-654. 10.1007\/s004310050685.","journal-title":"Eur J Pediatr"},{"key":"168_CR12","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1089\/109065703322783743","volume":"7","author":"MF Petry","year":"2003","unstructured":"Petry MF, Dieter T, Burin M, Giugliani R, Leistner S: Identification of a novel mutation in the ARSB gene that is frequent among Brazilian MPSVI patients. Genet Test. 2003, 7: 347-349. 10.1089\/109065703322783743.","journal-title":"Genet Test"},{"key":"168_CR13","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s10545-005-0020-2","volume":"28","author":"MF Petry","year":"2005","unstructured":"Petry MF, Nonemacher K, Sebben JC, Schwartz IV, Azevedo AC, Burin MG, et al: Mucopolysaccharidosis type VI: Identification of novel mutations on the arylsulphatase B gene in South American patients. J Inherit Metab Dis. 2005, 28: 1027-1034. 10.1007\/s10545-005-0020-2.","journal-title":"J Inherit Metab Dis"},{"key":"168_CR14","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/ajmg.a.30579","volume":"134A","author":"SJ Swiedler","year":"2005","unstructured":"Swiedler SJ, Beck M, Bajbouj M, Giugliani R, Schwartz I, Harmatz P, et al: Threshold effect of urinary glycosaminoglycans and the walk test as indicators of disease progression in a survey of subjects with Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). Am J Med Genet. 2005, 134A: 144-150. 10.1002\/ajmg.a.30579.","journal-title":"Am J Med Genet"},{"key":"168_CR15","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1002\/humu.20534","volume":"28","author":"L Karageorgos","year":"2007","unstructured":"Karageorgos L, Brooks DA, Pollard A, Melville EL, Hein LK, Clements PR, et al: Mutational analysis of 105 mucopolysaccharidosis type VI patients. Hum Mutat. 2007, 28: 897-903. 10.1002\/humu.20534.","journal-title":"Hum Mutat"},{"key":"168_CR16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/ana.410060405","volume":"6","author":"H Pilz","year":"1979","unstructured":"Pilz H, Von Figura K, Goebel HH: Deficiency of arylsulfatase B in 2 brothers aged 40 and 38 years (Maroteaux-Lamy syndrome, type B). Ann Neurol. 1979, 6: 315-325. 10.1002\/ana.410060405.","journal-title":"Ann Neurol"},{"key":"168_CR17","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1136\/jmg.28.7.499","volume":"28","author":"T Tonnesen","year":"1991","unstructured":"Tonnesen T, Gregersen HN, Guttler F: Normal MPS excretion, but dermatan sulphaturia, combined with a mild Maroteaux-Lamy phenotype. J Med Genet. 1991, 28: 499-501. 10.1136\/jmg.28.7.499.","journal-title":"J Med Genet"},{"key":"168_CR18","doi-asserted-by":"crossref","first-page":"21386","DOI":"10.1016\/S0021-9258(18)54649-4","volume":"266","author":"G Wicker","year":"1991","unstructured":"Wicker G, Prill V, Brooks D, Gibson G, Hopwood J, Von Figura K, et al: Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). An intermediate clinical phenotype caused by substitution of valine for glycine at position 137 of arylsulfatase B. J Biol Chem. 1991, 266: 21386-21391.","journal-title":"J Biol Chem"},{"key":"168_CR19","first-page":"454","volume":"54","author":"D Isbrandt","year":"1994","unstructured":"Isbrandt D, Arlt G, Brooks DA, Hopwood JJ, von Figura K, Peters C: Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): six unique arylsulfatase B gene alleles causing variable disease phenotypes. Am J Hum Genet. 1994, 54: 454-463.","journal-title":"Am J Hum Genet"},{"key":"168_CR20","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1259\/0007-1285-55-659-805","volume":"55","author":"DE Paterson","year":"1982","unstructured":"Paterson DE, Harper G, Weston HJ, Mattingley J: Maroteaux-Lamy syndrome, mild form--MPS VI B. Br J Radiol. 1982, 55: 805-812. 10.1259\/0007-1285-55-659-805.","journal-title":"Br J Radiol"},{"key":"168_CR21","first-page":"3421","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"EF Neufeld","year":"2001","unstructured":"Neufeld EF, Muenzer J: The Mucopolysaccharidoses. The Metabolic and Molecular Bases of Inherited Disease. Edited by: Scriver CR, Beaudet AL, Sly WS, Valle D. 2001, New York: McGraw-Hill, 3421-3452."},{"key":"168_CR22","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.ijporl.2005.01.017","volume":"69","author":"MA Simmons","year":"2005","unstructured":"Simmons MA, Bruce IA, Penney S, Wraith E, Rothera MP: Otorhinolaryngological manifestations of the mucopolysaccharidoses. Int J Pediatr Otorhinolaryngol. 2005, 69: 589-595. 10.1016\/j.ijporl.2005.01.017.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"168_CR23","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s10792-008-9213-7","volume":"29","author":"ST Koseoglu","year":"2009","unstructured":"Koseoglu ST, Harmatz P, Turbeville S, Nicely H: Reversed papilledema in an MPS VI patient with galsulfase (Naglazyme) therapy 29. Int Ophthalmol. 2009, 29: 267-269. 10.1007\/s10792-008-9213-7.","journal-title":"Int Ophthalmol"},{"key":"168_CR24","volume-title":"15th Annual ACMG Meeting March 12-16, Phoenix, Arizona","author":"P Harmatz","year":"2008","unstructured":"Harmatz P: Tracheostomy Reversal in an MPS VI Patient due to lmproved Pulmonary Function While on Enzyme Replacement Therapy (ERT). 15th Annual ACMG Meeting March 12-16, Phoenix, Arizona. 2008, Ref Type: Abstract"},{"key":"168_CR25","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1590\/S0021-75572008000200007","volume":"84","author":"A Cardoso-Santos","year":"2008","unstructured":"Cardoso-Santos A, Azevedo AC, Fagondes S, Burin MG, Giugliani R, Schwartz IV: Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome): assessment of joint mobility and grip and pinch strength. J Pediatr (Rio J). 2008, 84: 130-135. 10.1590\/S0021-75572008000200007.","journal-title":"J Pediatr (Rio J)"},{"key":"168_CR26","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1542\/peds.2006-2184","volume":"120","author":"R Giugliani","year":"2007","unstructured":"Giugliani R, Harmatz P, Wraith JE: Management guidelines for mucopolysaccharidosis VI. Pediatrics. 2007, 120: 405-418. 10.1542\/peds.2006-2184.","journal-title":"Pediatrics"},{"key":"168_CR27","volume-title":"Presentation at the annual meeting of the American Society of Human Genetics, November 12, 2008 Philadelphia, Pennsylvania","author":"C Lampe","year":"2008","unstructured":"Lampe C, Miebach E, Arash L, Mengel E, Beck M: Therapeutic response after two years of galsulfase enzyme replacement therapy (ERT) in five adult patients with Maroteaux-Lamy syndrome. Presentation at the annual meeting of the American Society of Human Genetics, November 12, 2008 Philadelphia, Pennsylvania. 2008, Ref Type: Abstract"},{"key":"168_CR28","volume-title":"J Inherit Metab Dis [2007]","author":"E Miebach","year":"2007","unstructured":"Miebach E, Thuemler A, Arash L, Bajbouj M, Link B, Kampmann C, et al: Adult patients with mucopolysaccharidosis VI. J Inherit Metab Dis [2007]. 2007, Ref Type: Abstract"},{"key":"168_CR29","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.ymgme.2005.02.008","volume":"85","author":"DA Brooks","year":"2005","unstructured":"Brooks DA, Gibson GJ, Karageorgos L, Hein LK, Robertson EF, Hopwood JJ: An index case for the attenuated end of the mucopolysaccharidosis type VI clinical spectrum. Mol Genet Metab. 2005, 85: 236-238. 10.1016\/j.ymgme.2005.02.008.","journal-title":"Mol Genet Metab"},{"key":"168_CR30","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1034\/j.1600-0455.2002.430108.x","volume":"43","author":"SL Shih","year":"2002","unstructured":"Shih SL, Lee YJ, Lin SP, Sheu CY, Blickman JG: Airway changes in children with mucopolysaccharidoses 6. Acta Radiol. 2002, 43: 40-43. 10.1034\/j.1600-0455.2002.430108.x.","journal-title":"Acta Radiol"},{"key":"168_CR31","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/0310057X8301100303","volume":"11","author":"D Baines","year":"1983","unstructured":"Baines D, Keneally J: Anaesthetic implications of the mucopolysaccharidoses: a fifteen-year experience in a children's hospital. Anaesth Intensive Care. 1983, 11: 198-202.","journal-title":"Anaesth Intensive Care"},{"key":"168_CR32","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/BF03026911","volume":"35","author":"D Baines","year":"1988","unstructured":"Baines D, Keneally J: Mucopolysaccharidoses and anaesthesia. Can J Anaesth. 1988, 35: 540-541. 10.1007\/BF03026911.","journal-title":"Can J Anaesth"},{"key":"168_CR33","first-page":"306","volume":"42","author":"YL Chan","year":"2001","unstructured":"Chan YL, Lin SP, Man TT, Cheng CR: Clinical experience in anesthetic management for children with mucopolysaccharidoses: Report of ten cases. Acta Paediatr Taiwan. 2001, 42: 306-308.","journal-title":"Acta Paediatr Taiwan"},{"key":"168_CR34","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00005792-198807000-00002","volume":"67","author":"GL Semenza","year":"1988","unstructured":"Semenza GL, Pyeritz RE: Respiratory complications of mucopolysaccharide storage disorders. Medicine (Baltimore). 1988, 67: 209-219.","journal-title":"Medicine (Baltimore)"},{"key":"168_CR35","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/BF01991908","volume":"154","author":"CF Wippermann","year":"1995","unstructured":"Wippermann CF, Beck M, Schranz D, Huth R, Michel-Behnke I, Jungst BK: Mitral and aortic regurgitation in 84 patients with mucopolysaccharidoses. Eur J Pediatr. 1995, 154: 98-101. 10.1007\/BF01991908.","journal-title":"Eur J Pediatr"},{"key":"168_CR36","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.1399-0004.2004.00277.x","volume":"66","author":"AC Azevedo","year":"2004","unstructured":"Azevedo AC, Schwartz IV, Kalakun L, Brustolin S, Burin MG, Beheregaray AP, et al: Clinical and biochemical study of 28 patients with mucopolysaccharidosis type VI. Clin Genet. 2004, 66: 208-213. 10.1111\/j.1399-0004.2004.00277.x.","journal-title":"Clin Genet"},{"key":"168_CR37","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2143\/AC.60.1.2005049","volume":"60","author":"MR Chen","year":"2005","unstructured":"Chen MR, Lin SP, Hwang HK, Yu CH: Cardiovascular changes in mucopolysaccharidoses in Taiwan. Acta Cardiol. 2005, 60: 51-53. 10.2143\/AC.60.1.2005049.","journal-title":"Acta Cardiol"},{"key":"168_CR38","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0022-3476(05)80441-X","volume":"120","author":"S Hayflick","year":"1992","unstructured":"Hayflick S, Rowe S, Kavanaugh-McHugh A, Olson JL, Valle D: Acute infantile cardiomyopathy as a presenting feature of mucopolysaccharidosis VI. J Pediatr. 1992, 120: 269-272. 10.1016\/S0022-3476(05)80441-X.","journal-title":"J Pediatr"},{"key":"168_CR39","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/BF02281012","volume":"4","author":"G Miller","year":"1983","unstructured":"Miller G, Partridge A: Mucopolysaccharidosis type VI presenting in infancy with endocardial fibroelastosis and heart failure. Pediatr Cardiol. 1983, 4: 61-62. 10.1007\/BF02281012.","journal-title":"Pediatr Cardiol"},{"key":"168_CR40","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1161\/01.CIR.85.1.188","volume":"85","author":"CT Tan","year":"1992","unstructured":"Tan CT, Schaff HV, Miller FA Jr, Edwards WD, Karnes PS: Valvular heart disease in four patients with Maroteaux-Lamy syndrome. Circulation. 1992, 85: 188-195.","journal-title":"Circulation"},{"key":"168_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.survophthal.2005.11.007","volume":"51","author":"JL Ashworth","year":"2006","unstructured":"Ashworth JL, Biswas S, Wraith E, Lloyd IC: Mucopolysaccharidoses and the eye. Surv Ophthalmol. 2006, 51: 1-17. 10.1016\/j.survophthal.2005.11.007.","journal-title":"Surv Ophthalmol"},{"key":"168_CR42","first-page":"32","volume":"7","author":"LS Leung","year":"1971","unstructured":"Leung LS, Weinstein GW, Hobson RR: Further electroretinographic studies of patients with mucopolysaccharidoses. Birth Defects Orig Artic Ser. 1971, 7: 32-40.","journal-title":"Birth Defects Orig Artic Ser"},{"key":"168_CR43","first-page":"337","volume":"25","author":"JW Spranger","year":"1970","unstructured":"Spranger JW, Koch F, McKusick VA, Natzschka J, Wiedemann HR, Zellweger H: Mucopolysaccharidosis VI (Maroteaux-Lamy's disease). Helv Paediatr Acta. 1970, 25: 337-362.","journal-title":"Helv Paediatr Acta"},{"key":"168_CR44","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/j.1399-0004.1987.tb02779.x","volume":"31","author":"S Vestermark","year":"1987","unstructured":"Vestermark S, Tonnesen T, Andersen MS, Guttler F: Mental retardation in a patient with Maroteaux-Lamy. Clin Genet. 1987, 31: 114-117. 10.1111\/j.1399-0004.1987.tb02779.x.","journal-title":"Clin Genet"},{"key":"168_CR45","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1136\/jmg.15.6.455","volume":"15","author":"HR Taylor","year":"1978","unstructured":"Taylor HR, Hollows FC, Hopwood JJ, Robertson EF: Report of a mucopolysaccharidosis occurring in Australian aborigines. J Med Genet. 1978, 15: 455-461. 10.1136\/jmg.15.6.455.","journal-title":"J Med Genet"},{"issue":"1-2","key":"168_CR46","first-page":"80","volume":"98","author":"V Valayannopoulos","year":"2009","unstructured":"Valayannopoulos V, Barbier V, Boddaert N, Arnoux JB, Lemmerer M, Lonlay de P: High Prevalence of Mental Impairment in a Series of 6 Patients with Mucopolysaccharidosis Type VI (Maroteaux-Lamy Syndrome). Mol Genet Metab. 2009, 98 (1-2): 80-Ref Type: Abstract","journal-title":"Mol Genet Metab"},{"key":"168_CR47","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1212\/01.wnl.0000269782.80107.fe","volume":"69","author":"L Vedolin","year":"2007","unstructured":"Vedolin L, Schwartz IV, Komlos M, Schuch A, Azevedo AC, Vieira T, et al: Brain MRI in mucopolysaccharidosis: effect of aging and correlation with biochemical findings. Neurology. 2007, 69: 917-924. 10.1212\/01.wnl.0000269782.80107.fe.","journal-title":"Neurology"},{"key":"168_CR48","first-page":"795","volume":"50","author":"WD Jin","year":"1992","unstructured":"Jin WD, Jackson CE, Desnick RJ, Schuchman EH: Mucopolysaccharidosis type VI: identification of three mutations in the arylsulfatase B gene of patients with the severe and mild phenotypes provides molecular evidence for genetic heterogeneity. Am J Hum Genet. 1992, 50: 795-800.","journal-title":"Am J Hum Genet"},{"key":"168_CR49","first-page":"400","volume":"116","author":"GP Schwartz","year":"1998","unstructured":"Schwartz GP, Cohen EJ: Hydrocephalus in Maroteaux-Lamy syndrome. Arch Ophthalmol. 1998, 116: 400.","journal-title":"Arch Ophthalmol"},{"key":"168_CR50","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000050383","volume":"35","author":"VI Vougioukas","year":"2001","unstructured":"Vougioukas VI, Berlis A, Kopp MV, Korinthenberg R, Spreer J, Van Velthoven V: Neurosurgical interventions in children with Maroteaux-Lamy syndrome. Case report and review of the literature. Pediatr Neurosurg. 2001, 35: 35-38. 10.1159\/000050383.","journal-title":"Pediatr Neurosurg"},{"key":"168_CR51","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1002\/ajmg.a.32294","volume":"146A","author":"MV Munoz-Rojas","year":"2008","unstructured":"Munoz-Rojas MV, Vieira T, Costa R, Fagondes S, John A, Jardim LB, et al: Intrathecal enzyme replacement therapy in a patient with mucopolysaccharidosis type I and symptomatic spinal cord compression. Am J Med Genet A. 2008, 146A: 2538-2544. 10.1002\/ajmg.a.32294.","journal-title":"Am J Med Genet A"},{"key":"168_CR52","doi-asserted-by":"publisher","first-page":"s34","DOI":"10.1016\/j.ymgme.2007.10.091","volume":"93","author":"S Sandberg","year":"2008","unstructured":"Sandberg S, Deanching M, Hoganson G, Wenger D, Whitley C: Pseudo-deficiency allele of N-acetylgalactosamine-4-sulfatase gene identified in a family with Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI)[abstract]. Mol Genet Metab 2008. 2008, 93: s34-10.1016\/j.ymgme.2007.10.091. Ref Type: Abstract","journal-title":"Mol Genet Metab 2008"},{"key":"168_CR53","doi-asserted-by":"publisher","first-page":"117R","DOI":"10.1093\/glycob\/cwf066","volume":"12","author":"JM Trowbridge","year":"2002","unstructured":"Trowbridge JM, Gallo RL: Dermatan sulfate: new functions from an old glycosaminoglycan. Glycobiology. 2002, 12: 117R-125R. 10.1093\/glycob\/cwf066.","journal-title":"Glycobiology"},{"key":"168_CR54","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1172\/JCI118617","volume":"97","author":"AC Crawley","year":"1996","unstructured":"Crawley AC, Brooks DA, Muller VJ, Petersen BA, Isaac EL, Bielicki J, et al: Enzyme replacement therapy in a feline model of Maroteaux-Lamy syndrome. J Clin Invest. 1996, 97: 1864-1873. 10.1172\/JCI118617.","journal-title":"J Clin Invest"},{"key":"168_CR55","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1172\/JCI119208","volume":"99","author":"AC Crawley","year":"1997","unstructured":"Crawley AC, Niedzielski KH, Isaac EL, Davey RC, Byers S, Hopwood JJ: Enzyme replacement therapy from birth in a feline model of mucopolysaccharidosis type VI. J Clin Invest. 1997, 99: 651-662. 10.1172\/JCI119208.","journal-title":"J Clin Invest"},{"key":"168_CR56","doi-asserted-by":"publisher","first-page":"27259","DOI":"10.1074\/jbc.271.44.27259","volume":"271","author":"G Yogalingam","year":"1996","unstructured":"Yogalingam G, Litjens T, Bielicki J, Crawley AC, Muller V, Anson DS, et al: Feline mucopolysaccharidosis type VI. Characterization of recombinant N-acetylgalactosamine 4-sulfatase and identification of a mutation causing the disease. J Biol Chem. 1996, 271: 27259-27265. 10.1074\/jbc.271.44.27259.","journal-title":"J Biol Chem"},{"key":"168_CR57","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1172\/JCI935","volume":"101","author":"AC Crawley","year":"1998","unstructured":"Crawley AC, Yogalingam G, Muller VJ, Hopwood JJ: Two mutations within a feline mucopolysaccharidosis type VI colony cause three different clinical phenotypes. J Clin Invest. 1998, 101: 109-119. 10.1172\/JCI935.","journal-title":"J Clin Invest"},{"key":"168_CR58","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1038\/labinvest.3780345","volume":"81","author":"CM Simonaro","year":"2001","unstructured":"Simonaro CM, Haskins ME, Schuchman EH: Articular chondrocytes from animals with a dermatan sulfate storage disease undergo a high rate of apoptosis and release nitric oxide and inflammatory cytokines: a possible mechanism underlying degenerative joint disease in the mucopolysaccharidoses. Lab Invest. 2001, 81: 1319-1328. 10.1038\/labinvest.3780345.","journal-title":"Lab Invest"},{"key":"168_CR59","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1203\/01.PDR.0000156510.96253.5A","volume":"57","author":"CM Simonaro","year":"2005","unstructured":"Simonaro CM, D'Angelo M, Haskins ME, Schuchman EH: Joint and bone disease in mucopolysaccharidoses VI and VII: identification of new therapeutic targets and biomarkers using animal models. Pediatr Res. 2005, 57: 701-707. 10.1203\/01.PDR.0000156510.96253.5A.","journal-title":"Pediatr Res"},{"key":"168_CR60","doi-asserted-by":"publisher","first-page":"112","DOI":"10.2353\/ajpath.2008.070564","volume":"172","author":"CM Simonaro","year":"2008","unstructured":"Simonaro CM, D'Angelo M, He X, Eliyahu E, Shtraizent N, Haskins ME, et al: Mechanism of glycosaminoglycan-mediated bone and joint disease: implications for the mucopolysaccharidoses and other connective tissue diseases. Am J Pathol. 2008, 172: 112-122. 10.2353\/ajpath.2008.070564.","journal-title":"Am J Pathol"},{"key":"168_CR61","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1002\/art.11093","volume":"48","author":"Z Ortutay","year":"2003","unstructured":"Ortutay Z, Polgar A, Gomor B, Geher P, Lakatos T, Glant TT, et al: Synovial fluid exoglycosidases are predictors of rheumatoid arthritis and are effective in cartilage glycosaminoglycan depletion. Arthritis Rheum. 2003, 48: 2163-2172. 10.1002\/art.11093.","journal-title":"Arthritis Rheum"},{"key":"168_CR62","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/(SICI)1098-1004(1996)7:4<361::AID-HUMU12>3.0.CO;2-0","volume":"7","author":"D Isbrandt","year":"1996","unstructured":"Isbrandt D, Hopwood JJ, von Figura K, Peters C: Two novel frameshift mutations causing premature stop codons in a patient with the severe form of Maroteaux-Lamy syndrome. Hum Mutat. 1996, 7: 361-363. 10.1002\/(SICI)1098-1004(1996)7:4<361::AID-HUMU12>3.0.CO;2-0.","journal-title":"Hum Mutat"},{"key":"168_CR63","first-page":"837","volume":"36","author":"EI Voskoboeva","year":"2000","unstructured":"Voskoboeva EI, Krasnopol'skaia KD, Peters K, Von Figura K: Identification of mutations in the arylsulfatase B gene in Russian mucopolysaccharidosis type VI patients. Genetika. 2000, 36: 837-843.","journal-title":"Genetika"},{"key":"168_CR64","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/humu.1380010509","volume":"1","author":"T Litjens","year":"1992","unstructured":"Litjens T, Morris CP, Robertson EF, Peters C, Von Figura K, Hopwood JJ: An N-acetylgalactosamine-4-sulfatase mutation (delta G238) results in a severe Maroteaux-Lamy phenotype. Hum Mutat. 1992, 1: 397-402. 10.1002\/humu.1380010509.","journal-title":"Hum Mutat"},{"key":"168_CR65","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/humu.10313","volume":"23","author":"L Karageorgos","year":"2004","unstructured":"Karageorgos L, Harmatz P, Simon J, Pollard A, Clements PR, Brooks DA, et al: Mutational analysis of mucopolysaccharidosis type VI patients undergoing a trial of enzyme replacement therapy. Hum Mutat. 2004, 23: 229-233. 10.1002\/humu.10313.","journal-title":"Hum Mutat"},{"key":"168_CR66","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1042\/bj2480755","volume":"248","author":"GJ Gibson","year":"1987","unstructured":"Gibson GJ, Saccone GT, Brooks DA, Clements PR, Hopwood JJ: Human N-acetylgalactosamine-4-sulphate sulphatase. Purification, monoclonal antibody production and native and subunit Mr values. Biochem J. 1987, 248: 755-764.","journal-title":"Biochem J"},{"key":"168_CR67","first-page":"710","volume":"48","author":"DA Brooks","year":"1991","unstructured":"Brooks DA, McCourt PA, Gibson GJ, Ashton LJ, Shutter M, Hopwood JJ: Analysis of N-acetylgalactosamine-4-sulfatase protein and kinetics in mucopolysaccharidosis type VI patients. Am J Hum Genet. 1991, 48: 710-719.","journal-title":"Am J Hum Genet"},{"key":"168_CR68","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.cccn.2004.10.009","volume":"353","author":"LK Hein","year":"2005","unstructured":"Hein LK, Meikle PJ, Dean CJ, Bockmann MR, Auclair D, Hopwood JJ, et al: Development of an assay for the detection of mucopolysaccharidosis type VI patients using dried blood-spots. Clin Chim Acta. 2005, 353: 67-74. 10.1016\/j.cccn.2004.10.009.","journal-title":"Clin Chim Acta"},{"key":"168_CR69","volume-title":"Ras Mol software program for 3-D molecular graphics visualization vs 2.7.3.1","author":"Roger Sayle","year":"2009","unstructured":"Sayle Roger: Ras Mol software program for 3-D molecular graphics visualization vs 2.7.3.1. 2009, Ref Type: Electronic Citation, [ http:\/\/www.openrasmol.com ]"},{"key":"168_CR70","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.ymgme.2008.02.012","volume":"94","author":"E Garrido","year":"2008","unstructured":"Garrido E, Cormand B, Hopwood JJ, Chabas A, Grinberg D, Vilageliu L: Maroteaux-Lamy syndrome: functional characterization of pathogenic mutations and polymorphisms in the arylsulfatase B gene. Mol Genet Metab. 2008, 94: 305-312. 10.1016\/j.ymgme.2008.02.012.","journal-title":"Mol Genet Metab"},{"key":"168_CR71","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/humu.1190","volume":"18","author":"T Litjens","year":"2001","unstructured":"Litjens T, Hopwood JJ: Mucopolysaccharidosis type VI: Structural and clinical implications of mutations in N-acetylgalactosamine-4-sulfatase. Hum Mutat. 2001, 18: 282-295. 10.1002\/humu.1190.","journal-title":"Hum Mutat"},{"key":"168_CR72","first-page":"1127","volume":"58","author":"T Litjens","year":"1996","unstructured":"Litjens T, Brooks DA, Peters C, Gibson GJ, Hopwood JJ: Identification, expression, and biochemical characterization of N-acetylgalactosamine-4-sulfatase mutations and relationship with clinical phenotype in MPS-VI patients. Am J Hum Genet. 1996, 58: 1127-1134.","journal-title":"Am J Hum Genet"},{"key":"168_CR73","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1038\/ejhg.2009.19","volume":"17","author":"A Zanetti","year":"2009","unstructured":"Zanetti A, Ferraresi E, Picci L, Filocamo M, Parini R, Rosano C, et al: Segregation analysis in a family at risk for the Maroteaux-Lamy syndrome conclusively reveals c.1151G > A (p.S384N) as to be a polymorphism. Eur J Hum Genet. 2009, 17: 1160-1164. 10.1038\/ejhg.2009.19.","journal-title":"Eur J Hum Genet"},{"key":"168_CR74","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10545-007-0529-7","volume":"30","author":"AM Montano","year":"2007","unstructured":"Montano AM, Tomatsu S, Gottesman GS, Smith M, Orii T: International Morquio A Registry: clinical manifestation and natural course of Morquio A disease. J Inherit Metab Dis. 2007, 30: 165-174. 10.1007\/s10545-007-0529-7.","journal-title":"J Inherit Metab Dis"},{"key":"168_CR75","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/j.1399-0004.1986.tb01899.x","volume":"30","author":"M Burch","year":"1986","unstructured":"Burch M, Fensom AH, Jackson M, Pitts-Tucker T, Congdon PJ: Multiple sulphatase deficiency presenting at birth. Clin Genet. 1986, 30: 409-415. 10.1111\/j.1399-0004.1986.tb01899.x.","journal-title":"Clin Genet"},{"key":"168_CR76","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.braindev.2007.10.007","volume":"30","author":"U Yis","year":"2008","unstructured":"Yis U, Pepe S, Kurul SH, Ballabio A, Cosma MP, Dirik E: Multiple sulfatase deficiency in a Turkish family resulting from a novel mutation. Brain Dev. 2008, 30: 374-377. 10.1016\/j.braindev.2007.10.007.","journal-title":"Brain Dev"},{"key":"168_CR77","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.cca.2006.03.029","volume":"372","author":"G Civallero","year":"2006","unstructured":"Civallero G, Michelin K, de MJ, Viapiana M, Burin M, Coelho JC, et al: Twelve different enzyme assays on dried-blood filter paper samples for detection of patients with selected inherited lysosomal storage diseases. Clin Chim Acta. 2006, 372: 98-102. 10.1016\/j.cca.2006.03.029.","journal-title":"Clin Chim Acta"},{"key":"168_CR78","volume-title":"Ref Type: Electronic Citation","author":"Maroteaux-Lamy syndrome; Mucopolysaccharidosis VI; MPS VI; diagnostic and prenatal (antenatal) tests.","year":"2008","unstructured":"Maroteaux-Lamy syndrome; Mucopolysaccharidosis VI; MPS VI; diagnostic and prenatal (antenatal) tests. 2008, Ref Type: Electronic Citation. [ http:\/\/www.genetests.org ]"},{"key":"168_CR79","volume-title":"Naglazyme Prescribing Information","author":"Naglazyme [BioMarin]","year":"2005","unstructured":"Naglazyme [BioMarin]: Naglazyme Prescribing Information. 2005, Ref Type: Pamphlet"},{"key":"168_CR80","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S1096-7192(03)00007-6","volume":"78","author":"D Auclair","year":"2003","unstructured":"Auclair D, Hopwood JJ, Brooks DA, Lemontt JF, Crawley AC: Replacement therapy in Mucopolysaccharidosis type VI: advantages of early onset of therapy. Mol Genet Metab. 2003, 78: 163-174. 10.1016\/S1096-7192(03)00007-6.","journal-title":"Mol Genet Metab"},{"key":"168_CR81","volume-title":"Clin Genet","author":"JJ McGill","year":"2009","unstructured":"McGill JJ, Inwood AC, Coman DJ, Lipke ML, de LD, Swiedler SJ, et al: Enzyme replacement therapy for mucopolysaccharidosis VI from 8 weeks of age - a sibling control study. Clin Genet. 2009,"},{"key":"168_CR82","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1373\/clinchem.2006.077263","volume":"53","author":"D Wang","year":"2007","unstructured":"Wang D, Wood T, Sadilek M, Scott CR, Turecek F, Gelb MH: Tandem mass spectrometry for the direct assay of enzymes in dried blood spots: application to newborn screening for mucopolysaccharidosis II (Hunter disease). Clin Chem. 2007, 53: 137-140. 10.1373\/clinchem.2006.077263.","journal-title":"Clin Chem"},{"key":"168_CR83","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1373\/clinchem.2004.035907","volume":"50","author":"Y Li","year":"2004","unstructured":"Li Y, Scott CR, Chamoles NA, Ghavami A, Pinto BM, Turecek F, et al: Direct multiplex assay of lysosomal enzymes in dried blood spots for newborn screening. Clin Chem. 2004, 50: 1785-1796. 10.1373\/clinchem.2004.035907.","journal-title":"Clin Chem"},{"key":"168_CR84","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10545-006-0265-4","volume":"29","author":"MH Gelb","year":"2006","unstructured":"Gelb MH, Turecek F, Scott CR, Chamoles NA: Direct multiplex assay of enzymes in dried blood spots by tandem mass spectrometry for the newborn screening of lysosomal storage disorders. J Inherit Metab Dis. 2006, 29: 397-404. 10.1007\/s10545-006-0265-4.","journal-title":"J Inherit Metab Dis"},{"key":"168_CR85","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1651-2227.2008.00652.x","volume":"97","author":"D Matern","year":"2008","unstructured":"Matern D: Newborn screening for lysosomal storage disorders. Acta Paediatr Suppl. 2008, 97: 33-37. 10.1111\/j.1651-2227.2008.00652.x.","journal-title":"Acta Paediatr Suppl"},{"key":"168_CR86","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1373\/clinchem.2008.104711","volume":"54","author":"XK Zhang","year":"2008","unstructured":"Zhang XK, Elbin CS, Chuang WL, Cooper SK, Marashio CA, Beauregard C, et al: Multiplex Enzyme Assay Screening of Dried Blood Spots for Lysosomal Storage Disorders by Using Tandem Mass Spectrometry. Clin Chem. 2008, 54: 1725-1728. 10.1373\/clinchem.2008.104711.","journal-title":"Clin Chem"},{"key":"168_CR87","volume-title":"Management Guidelines for MPS VI","author":"R Giugliani","year":"2007","unstructured":"Giugliani R, Harmatz P, Wraith E: Management Guidelines for MPS VI. 2007, Ref Type: Electronic Citation, [ https:\/\/articleworks.cadmus.com\/doc\/782823 ]"},{"key":"168_CR88","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1056\/NEJM198412203112504","volume":"311","author":"W Krivit","year":"1984","unstructured":"Krivit W, Pierpont ME, Ayaz K, Tsai M, Ramsay NK, Kersey JH, et al: Bone-marrow transplantation in the Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI). Biochemical and clinical status 24 months after transplantation. N Engl J Med. 1984, 311: 1606-1611. 10.1056\/NEJM198412203112504.","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"168_CR89","first-page":"87","volume":"10","author":"W Krivit","year":"1992","unstructured":"Krivit W, Shapiro E, Hoogerbrugge PM, Moser HW: State of the art review. Bone marrow transplantation treatment for storage diseases. Keystone. January 23, 1992. Bone Marrow Transplant. 1992, 10 (Suppl 1): 87-96.","journal-title":"Bone Marrow Transplant"},{"key":"168_CR90","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1442-200X.1994.tb03125.x","volume":"36","author":"M Imaizumi","year":"1994","unstructured":"Imaizumi M, Gushi K, Kurobane I, Inoue S, Suzuki J, Koizumi Y, et al: Long-term effects of bone marrow transplantation for inborn errors of metabolism: a study of four patients with lysosomal storage diseases. Acta Paediatr Jpn. 1994, 36: 30-36.","journal-title":"Acta Paediatr Jpn"},{"key":"168_CR91","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/S0140-6736(95)92597-X","volume":"345","author":"PM Hoogerbrugge","year":"1995","unstructured":"Hoogerbrugge PM, Brouwer OF, Bordigoni P, Ringden O, Kapaun P, Ortega JJ, et al: Allogeneic bone marrow transplantation for lysosomal storage diseases. The European Group for Bone Marrow Transplantation. Lancet. 1995, 345: 1398-1402. 10.1016\/S0140-6736(95)92597-X.","journal-title":"Lancet"},{"key":"168_CR92","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/00019052-199904000-00007","volume":"12","author":"W Krivit","year":"1999","unstructured":"Krivit W, Peters C, Shapiro EG: Bone marrow transplantation as effective treatment of central nervous system disease in globoid cell leukodystrophy, metachromatic leukodystrophy, adrenoleukodystrophy, mannosidosis, fucosidosis, aspartylglucosaminuria, Hurler, Maroteaux-Lamy, and Sly syndromes, and Gaucher disease type III. Curr Opin Neurol. 1999, 12: 167-176. 10.1097\/00019052-199904000-00007.","journal-title":"Curr Opin Neurol"},{"key":"168_CR93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/S0004-282X2006000100001","volume":"64","author":"MC Lange","year":"2006","unstructured":"Lange MC, Teive HA, Troiano AR, Bitencourt M, Funke VA, Setubal DC, et al: Bone marrow transplantation in patients with storage diseases: a developing country experience. Arq Neuropsiquiatr. 2006, 64: 1-4.","journal-title":"Arq Neuropsiquiatr"},{"key":"168_CR94","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.cca.2006.06.024","volume":"374","author":"W Dou","year":"2006","unstructured":"Dou W, Peng C, Zheng J, Sheng HZ, Gu X, Chen J, et al: Two novel mutations of the arylsulfatase B gene in a Chinese MPS VI child undergoing bone marrow transplantation therapy. Clin Chim Acta. 2006, 374: 171-172. 10.1016\/j.cca.2006.06.024.","journal-title":"Clin Chim Acta"},{"key":"168_CR95","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s12519-008-0031-9","volume":"4","author":"CC Wang","year":"2008","unstructured":"Wang CC, Hwu WL, Lin KH: Long-term follow-up of a girl with Maroteaux-Lamy syndrome after bone marrow transplantation. World J Pediatr. 2008, 4: 152-154. 10.1007\/s12519-008-0031-9.","journal-title":"World J Pediatr"},{"key":"168_CR96","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1023\/A:1005447232027","volume":"22","author":"E Herskhovitz","year":"1999","unstructured":"Herskhovitz E, Young E, Rainer J, Hall CM, Lidchi V, Chong K, et al: Bone marrow transplantation for Maroteaux-Lamy syndrome (MPS VI): long-term follow-up. J Inherit Metab Dis. 1999, 22: 50-62. 10.1023\/A:1005447232027.","journal-title":"J Inherit Metab Dis"},{"issue":"Suppl 2","key":"168_CR97","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.1038\/bmt.2008.62","volume":"41","author":"AM Rovelli","year":"2008","unstructured":"Rovelli AM: The controversial and changing role of haematopoietic cell transplantation for lysosomal storage disorders: an update. Bone Marrow Transplant. 2008, 41 (Suppl 2): S87-S89. 10.1038\/bmt.2008.62.","journal-title":"Bone Marrow Transplant"},{"key":"168_CR98","first-page":"178","volume-title":"Presented at the annual meeting of the American Society for Human Genetics 2008","author":"V Valayannopoulos","year":"2008","unstructured":"Valayannopoulos V, Raff M, Turbeville S, Nicely H: A Follow-Up of Enzyme Replacement Therapy in Two MPS Vl Patients with Poorly Engrafted Bone Marrow Transplantation [abstract]. Presented at the annual meeting of the American Society for Human Genetics 2008. 2008, 178-Ref Type: Abstract"},{"key":"168_CR99","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.jpeds.2004.03.018","volume":"144","author":"P Harmatz","year":"2004","unstructured":"Harmatz P, Whitley CB, Waber L, Pais R, Steiner R, Plecko B, et al: Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). J Pediatr. 2004, 144: 574-580. 10.1016\/j.jpeds.2004.03.018.","journal-title":"J Pediatr"},{"key":"168_CR100","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/08035320510028139","volume":"94","author":"P Harmatz","year":"2005","unstructured":"Harmatz P, Kramer WG, Hopwood JJ, Simon J, Butensky E, Swiedler SJ: Pharmacokinetic profile of recombinant human N-acetylgalactosamine 4-sulphatase enzyme replacement therapy in patients with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): a phase I\/II study. Acta Paediatr Suppl. 2005, 94: 61-68. 10.1080\/08035320510028139.","journal-title":"Acta Paediatr Suppl"},{"key":"168_CR101","doi-asserted-by":"publisher","first-page":"e681","DOI":"10.1542\/peds.2004-1023","volume":"115","author":"P Harmatz","year":"2005","unstructured":"Harmatz P, Ketteridge D, Giugliani R, Guffon N, Teles EL, Miranda MC, et al: Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-acetylgalactosamine 4-sulfatase. Pediatrics. 2005, 115: e681-e689. 10.1542\/peds.2004-1023.","journal-title":"Pediatrics"},{"key":"168_CR102","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.jpeds.2005.12.014","volume":"148","author":"P Harmatz","year":"2006","unstructured":"Harmatz P, Giugliani R, Schwartz I, Guffon N, Teles EL, Miranda MC, et al: Enzyme replacement therapy for mucopolysaccharidosis VI: a phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study. J Pediatr. 2006, 148: 533-539. 10.1016\/j.jpeds.2005.12.014.","journal-title":"J Pediatr"},{"key":"168_CR103","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.ymgme.2008.04.001","volume":"94","author":"P Harmatz","year":"2008","unstructured":"Harmatz P, Giugliani R, Schwartz IV, Guffon N, Teles EL, Miranda MC, et al: Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase. Mol Genet Metab. 2008, 94: 469-475. 10.1016\/j.ymgme.2008.04.001.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"168_CR104","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s10545-009-9007-8","volume":"33","author":"P Harmatz","year":"2010","unstructured":"Harmatz P, Yu ZF, Giugliani R, Schwartz IV, Guffon N, Teles EL, et al: Enzyme replacement therapy for mucopolysaccharidosis VI: evaluation of long-term pulmonary function in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase. J Inherit Metab Dis. 2010, 33 (1): 51-60. 10.1007\/s10545-009-9007-8.","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"168_CR105","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s10792-008-9213-7","volume":"29","author":"ST Koseoglu","year":"2008","unstructured":"Koseoglu ST, Harmatz P, Turbeville S, Nicely H: Reversed papilledema in an MPS VI patient with galsulfase (Naglazyme(R)) therapy. Int Ophthalmol. 2008, 29 (4): 267-269. 10.1007\/s10792-008-9213-7.","journal-title":"Int Ophthalmol"},{"key":"168_CR106","volume-title":"J Inherit Metab Dis","author":"T Magalhaes","year":"2007","unstructured":"Magalhaes T, Teles E, Breda J, Nicely H, Turbeville S: Ophthalmologic Evaluation of MPS VI Patients Following Treatment with Galsulfase Enzyme Replacement Therapy [abstract]. J Inherit Metab Dis. 2007, Ref Type: Abstract"},{"key":"168_CR107","doi-asserted-by":"publisher","first-page":"e714","DOI":"10.1542\/peds.2007-0665","volume":"121","author":"KH Kim","year":"2008","unstructured":"Kim KH, Decker C, Burton BK: Successful management of difficult infusion-associated reactions in a young patient with mucopolysaccharidosis type VI receiving recombinant human arylsulfatase B (galsulfase [Naglazyme]). Pediatrics. 2008, 121: e714-e717. 10.1542\/peds.2007-0665.","journal-title":"Pediatrics"},{"key":"168_CR108","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/NAN.0b013e31819228ee","volume":"32","author":"C Tifft","year":"2009","unstructured":"Tifft C, Proud V, Levy P, DeMarco K, Nicely H, Turbeville S: Enzyme replacement therapy in the home setting for mucopolysaccharidosis VI: a survey of patient characteristics and physicians' early findings in the United States. J Infus Nurs. 2009, 32: 45-52. 10.1097\/NAN.0b013e31819228ee.","journal-title":"J Infus Nurs"},{"key":"168_CR109","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s10545-008-0980-0","volume":"31","author":"S Bagewadi","year":"2008","unstructured":"Bagewadi S, Roberts J, Mercer J, Jones S, Stephenson J, Wraith JE: Home treatment with Elaprase and Naglazyme is safe in patients with mucopolysaccharidoses types II and VI, respectively. J Inherit Metab Dis. 2008, 31: 733-737. 10.1007\/s10545-008-0980-0.","journal-title":"J Inherit Metab Dis"},{"key":"168_CR110","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.ymgme.2009.04.007","volume":"97","author":"BK Burton","year":"2009","unstructured":"Burton BK, Wiesman C, Paras A, Kim K, Katz R: Home infusion therapy is safe and enhances compliance in patients with mucopolysaccharidoses. Mol Genet Metab. 2009, 97: 234-236. 10.1016\/j.ymgme.2009.04.007.","journal-title":"Mol Genet Metab"},{"key":"168_CR111","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1101\/gr.4413105","volume":"15","author":"GA Thorisson","year":"2005","unstructured":"Thorisson GA, Smith AV, Krishnan L, Stein LD: The International HapMap Project Web site. Genome Res. 2005, 15: 1592-1593. 10.1101\/gr.4413105.","journal-title":"Genome Res"},{"key":"168_CR112","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1203\/01.pdr.0000203090.41012.a6","volume":"59","author":"D Auclair","year":"2006","unstructured":"Auclair D, Hein LK, Hopwood JJ, Byers S: Intra-articular enzyme administration for joint disease in feline mucopolysaccharidosis VI: enzyme dose and interval. Pediatr Res. 2006, 59: 538-543. 10.1203\/01.pdr.0000203090.41012.a6.","journal-title":"Pediatr Res"},{"key":"168_CR113","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.ymgme.2007.04.009","volume":"91","author":"D Auclair","year":"2007","unstructured":"Auclair D, Hopwood JJ, Lemontt JF, Chen L, Byers S: Long-term intra-articular administration of recombinant human N-acetylgalactosamine-4-sulfatase in feline mucopolysaccharidosis VI. Mol Genet Metab. 2007, 91: 352-361. 10.1016\/j.ymgme.2007.04.009.","journal-title":"Mol Genet Metab"},{"key":"168_CR114","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ymgme.2006.12.012","volume":"91","author":"P Dickson","year":"2007","unstructured":"Dickson P, McEntee M, Vogler C, Le S, Levy B, Peinovich M, et al: Intrathecal enzyme replacement therapy: successful treatment of brain disease via the cerebrospinal fluid. Mol Genet Metab. 2007, 91: 61-68. 10.1016\/j.ymgme.2006.12.012.","journal-title":"Mol Genet Metab"},{"issue":"4","key":"168_CR115","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.ymgme.2009.11.008","volume":"99","author":"MV Munoz-Rojas","year":"2009","unstructured":"Munoz-Rojas MV, Horovitz DD, Jardim LB, Raymundo M, Llerena JC Jr, de Magalhaes TD, et al: Intrathecal administration of recombinant human N-acetylgalactosamine 4-sulfatase to a MPS VI patient with pachymeningitis cervicalis. Mol Genet Metab. 2009, 99 (4): 346-50. 10.1016\/j.ymgme.2009.11.008.","journal-title":"Mol Genet Metab"},{"key":"168_CR116","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1353\/hcr.0.0011","volume":"38","author":"VA Moyer","year":"2008","unstructured":"Moyer VA, Calonge N, Teutsch SM, Botkin JR: Expanding newborn screening: process, policy, and priorities. Hastings Cent Rep. 2008, 38: 32-39. 10.1353\/hcr.0.0011.","journal-title":"Hastings Cent Rep"},{"key":"168_CR117","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/ajmg.a.20314","volume":"123A","author":"J Nelson","year":"2003","unstructured":"Nelson J, Crowhurst J, Carey B, Greed L: Incidence of the mucopolysaccharidoses in Western Australia. Am J Med Genet A. 2003, 123A: 310-313. 10.1002\/ajmg.a.20314.","journal-title":"Am J Med Genet A"},{"key":"168_CR118","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1542\/peds.105.1.e10","volume":"105","author":"DA Applegarth","year":"2000","unstructured":"Applegarth DA, Toone JR, Lowry RB: Incidence of inborn errors of metabolism in British Columbia, 1969-1996. Pediatrics. 2000, 105: e10-10.1542\/peds.105.1.e10.","journal-title":"Pediatrics"},{"key":"168_CR119","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/BF00206770","volume":"85","author":"RB Lowry","year":"1990","unstructured":"Lowry RB, Applegarth DA, Toone JR, MacDonald E, Thunem NY: An update on the frequency of mucopolysaccharide syndromes in British Columbia. Hum Genet. 1990, 85: 389-390. 10.1007\/BF00206770.","journal-title":"Hum Genet"},{"key":"168_CR120","first-page":"43","volume":"6","author":"H Michelakakis","year":"1995","unstructured":"Michelakakis H, Dimitriou E, Tsagaraki S, Giouroukos S, Schulpis K, Bartsocas CS: Lysosomal storage diseases in Greece. Genet Couns. 1995, 6: 43-47.","journal-title":"Genet Couns"},{"key":"168_CR121","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s004390050641","volume":"101","author":"J Nelson","year":"1997","unstructured":"Nelson J: Incidence of the mucopolysaccharidoses in Northern Ireland. Hum Genet. 1997, 101: 355-358. 10.1007\/s004390050641.","journal-title":"Hum Genet"},{"key":"168_CR122","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.cca.2008.04.014","volume":"394","author":"WD Lin","year":"2008","unstructured":"Lin WD, Lin SP, Wang CH, Hwu WL, Chuang CK, Lin SJ, et al: Genetic analysis of mucopolysaccharidosis type VI in Taiwanese patients. Clin Chim Acta. 2008, 394: 89-93. 10.1016\/j.cca.2008.04.014.","journal-title":"Clin Chim Acta"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-1172-5-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1750-1172-5-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-1172-5-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T18:56:06Z","timestamp":1635188166000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/1750-1172-5-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,12]]},"references-count":122,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["168"],"URL":"https:\/\/doi.org\/10.1186\/1750-1172-5-5","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,12]]},"article-number":"5"}}